Physicians in ACOs believe pharma companies could help reduce the cost of healthcare—but suspect they won’t
Healthcare providers believe that the pharmaceutical industry could play an important role in helping value-based healthcare providers such as accountable care organizations to deliver better care at lower cost. But pharma companies currently do a poor job of delivering the kind of data needed to accomplish that goal, according to a survey of physicians in value-based delivery models, conducted by Oliver Wyman, a New York-based management consulting firm.
The city of Chicago offers a host of activities, museums, shopping and cultural activities for attendees of the American Heart Association (AHA) Scientific Sessions 2006.
Recent reports of Medicare Part D beneficiaries who have been caught in the doughnut hole have related how some have cut back on medications.
An observational study of 51 outpatient practices found that about
7 in 1,000 outpatients were administered a prescription that
violated an FDA black box warning and that <1% of those patients
had an adverse drug event (ADE) as a result.
USP has been awarded a cooperative agreement with the Centers for Medicare and Medicaid Services (CMS) to revise the Part D Prescription Drug Benefit Model Guidelines.
While Hurricane Katrina has disrupted healthcare for millions of people, one beneficial outcome may be more public and private efforts to develop a national electronic health records (EHR) system.
Bethesda, Md.-The daily activities of health-system pharmacists are greatly
affected by the Health Insurance Portability and Accountability Act of 1996
(HIPAA). To help keep practitioners up-to-date with current regulations
and other important information, ASHP has developed an online resource center
on its website, www.ashp.org.